UK markets closed

TCM Biotech International Corp. (4169.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
55.60+0.40 (+0.72%)
At close: 02:59PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
894,697
969,619
802,421
702,046
737,078
Cost of revenue
424,689
489,451
353,933
343,328
368,154
Gross profit
470,008
480,168
448,488
358,718
368,924
Operating expenses
Research development
77,455
77,464
81,800
80,449
71,530
Selling general and administrative
374,018
380,375
340,902
276,138
259,592
Total operating expenses
451,473
457,839
422,702
356,587
331,122
Operating income or loss
18,535
22,329
25,786
2,131
37,802
Interest expense
2,792
2,772
2,385
1,971
1,947
Income before tax
16,080
22,032
23,125
2,257
36,134
Income tax expense
2,657
3,458
4,860
384
10,592
Income from continuing operations
13,423
18,574
18,265
1,873
25,542
Net income
13,423
18,574
18,265
1,873
25,542
Net income available to common shareholders
13,423
18,574
18,265
1,873
25,542
Basic EPS
0.26
-
0.37
0.04
0.50
Diluted EPS
0.26
-
0.37
0.04
0.50
Basic average shares
51,420
-
49,365
50,736
50,485
Diluted average shares
51,474
-
49,365
50,740
50,529